六块爱理不理 8块高攀不起查看全文
格隆汇11月15日丨Aytu BioPharma(AYTU.US)盘前涨18.76%,报0.23美元。公司2023年Q1财报实现营收2765.5万美元,前值为2189.7万美元,预期值为2430万美元,超出市场预期13.81%;每股收益为-0.06美元,前值为-0.33美元,预期值为-0.18美元,超出市场预期66.67%。 网页链接
$Aytu BioScience(AYTU)$ 8-K Current report, item 8.01 Accession Number: 0001654954-20-002843 Act: 34 Size: 27 KB 网页链接
$Aytu BioScience(AYTU)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0000919574-20-002440 Act: 34 Size: 182 KB 网页链接
$Aytu BioScience(AYTU)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001213900-20-006311 Act: 34 Size: 453 KB 网页链接
$Aytu BioScience(AYTU)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001213900-20-006269 Act: 33 Size: 341 KB 网页链接
$Aytu BioScience(AYTU)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001213900-20-006183 Act: 33 Size: 339 KB 网页链接
$Aytu BioScience(AYTU)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001213900-20-006187 Act: 34 Size: 482 KB 网页链接
$Aytu BioScience(AYTU)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000919574-20-002393 Size: 54 KB 网页链接
$Aytu BioScience(AYTU)$ 8-K Current report, item 8.01 Accession Number: 0001654954-20-002568 Act: 34 Size: 25 KB 网页链接
$Aytu BioScience(AYTU)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001535610-20-000080 Act: 34 Size: 15 KB 网页链接
$Aytu BioScience(AYTU)$ DEF 14A Other definitive proxy statements Accession Number: 0001213900-20-005421 Act: 34 Size: 372 KB 网页链接